Loading…

Antimicrobial susceptibility of skin-colonizing S. aureus strains in children with atopic dermatitis

Children with atopic dermatitis (AD) are prone to recurrent cutaneous and occasional systemic infections caused by Staphylococcus aureus. Antibiotic therapy represents an important component of the overall management of AD, especially during exacerbations of disease. Erythromycin is still widely use...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric allergy and immunology 2004-10, Vol.15 (5), p.474-477
Main Author: Hoeger, Peter H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Children with atopic dermatitis (AD) are prone to recurrent cutaneous and occasional systemic infections caused by Staphylococcus aureus. Antibiotic therapy represents an important component of the overall management of AD, especially during exacerbations of disease. Erythromycin is still widely used as a first‐line antibiotic for this indication. We studied 115 consecutive children (mean age: 2.7 yr, range: 0.2–15) with moderate to severe AD (mean SCORAD: 43.2, range: 16–77) presenting to our outpatient department. Staphylococcus aureus was isolated from 100 of 115 (87%). Antimicrobial susceptibility testing revealed resistance against erythromycin in 18 and against roxithromycin in 19%, respectively. Six percentage of the strains were resistant or only intermediately susceptible to fusidic acid, 13% to amoxicillin and 1% to clindamycin. All strains isolated were susceptible to oxacillin, amoxicillin/clavulanic acid, cefadroxil and cefuroxim. The high rate of primary resistance to macrolides should be born in mind when starting antibiotic therapy in children with AD. Since Gram‐positive cocci represent the only relevant microbial agents in AD, first generation cephalosporins such as cefadroxil, whose antimicrobial spectrum is basically restricted to Gram‐positive bacteria, would appear to be the ideal first‐line antibiotics for the treatment of bacterial superinfections.
ISSN:0905-6157
1399-3038
DOI:10.1111/j.1399-3038.2004.00182.x